Helix VaxApp gets approval from NHS England to boost vaccine management

London, UK – MedicalDirector UK’s innovative Helix VaxApp has today received approval from NHS England to be used across the health service’s COVID and flu vaccination programme.

This milestone marks a significant achievement in the ongoing efforts to combat COVID-19 virus variants and support public health efforts across the UK.

Medical Director UK is part of Telstra Health UK, a leader in healthcare data and insight with metrics that have been adopted as global standards in healthcare. Telstra Health UK is part of Telstra Health, which provides digital solutions and services to healthcare providers and governments across the care continuum in Australia and internationally.

The Helix VaxApp is a cutting-edge vaccination management and tracking system designed to streamline the vaccination process and improve patient outcomes. With its intuitive user interface and robust data management capabilities, the Helix VaxApp enables healthcare providers to efficiently manage vaccine supplies, track patient vaccination status, and monitor adverse reactions.

Helix VaxApp has been developed in line with the UK government’s £484 million investment program to upgrade clinical health record technology and is available as part of NHS funding.

“Helix VaxApp is a simple, secure, cloud-based solution that enables management of COVID 19 and flu vaccinations from anywhere, which allows providers to be fully mobile and go to their patients’ locations whether that be a care home, school or even a patient’s home,” Jack Gibson, Product Lead for MedicalDirector said. “It can be accessed through a web browser on a tablet or laptop, with no software installation necessary. The system is fully mobile which means it can be used for vaccinations with only a Wi-Fi connection or phone hotspot, connecting seamlessly to core NHS Spine services like Personal Demographics Service (PDS), as well as the National Immunisation Management System. The software can be up and running in days with minimal training necessary and has full integration into the patient clinical system including submissions to platforms that process payments against the vaccination events.”

Following a successful pilot program, the Helix VaxApp has been approved for rollout across the NHS. This means that healthcare providers across the country will now have funded access to this innovative vaccination management system, allowing them to provide faster, more efficient care to patients.

“We are thrilled to receive rollout approval from NHS England,” continued Jack Gibson “The Helix VaxApp is a game-changer in the fight against COVID-19, and we believe it will be an invaluable tool for healthcare providers across the country as they work to vaccinate as many people as possible. We look forward to building our partnership with NHS England to support public health efforts and improve patient outcomes.”

If you’d like to upgrade your vaccination solution as part of your preparations for a spring booster campaign, contact Jack Gibson (jack.gibson@medicaldirector.com) for a demonstration.